Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2009
10/13/2009US7601494 Method of screening candidate compounds for susceptibility to biliary excretion
10/13/2009US7601352 Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA
10/13/2009US7601349 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
10/13/2009US7601344 Von Hippel-Lindau (VHL) gene in cancer cells which express neuropeptide Y, neurofilament, and microtubule associated protein 2; plasmids; Parkinson's disease, amyotrophic lateral sclerosis, Huntington's chorea, Alzheimer's disease, brain infarction, spinal cord injury, brain contusion or malignant tumor
10/13/2009US7601343 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides
10/13/2009US7601342 Producing a substantially pure cytotoxic population of educated, antigen-specific immune effector cells as adoptive immunostimulants;using hybrid cells generated by fusion of a dendritic cell and a tumor or cancer cell that expresses cell-surface antigens; antitumor agents; anticarcinogenic agents
10/13/2009CA2263281C Modified acyl-acp desaturase
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2222650C Tnf-.alpha. converting enzyme
10/13/2009CA2103583C Recombinant transferrins, transferrin half-molecules and mutants thereof
10/08/2009WO2009124321A1 Methods and compositions for improving the production of fuels in microorganisms
10/08/2009WO2009124213A2 Dental stem cell differentiation
10/08/2009WO2009123748A1 Method of obtaining antibodies of interest and nucleotides encoding same
10/08/2009WO2009123479A1 Gene expression control in plants
10/08/2009WO2009123349A1 Method for proliferation of pluripotent stem cell
10/08/2009WO2009122747A1 Method for preparation of platelet from ips cell
10/08/2009WO2009122580A1 Method of bioassaying yokukansan
10/08/2009WO2009122541A1 Liquid culture media for extracorporeal fertilization and culture of human embryo and method of extracorporeal fertilization and culture of human embryo
10/08/2009WO2009122413A1 Motor neurons developed from stem cells
10/08/2009WO2009121999A1 Specific promoter of stem cells
10/08/2009WO2009121868A2 Microbioreactor and microtiter plate comprising a plurality of microbioreactors
10/08/2009WO2009121804A1 Drug fusions and conjugates
10/08/2009WO2009091659A3 Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
10/08/2009WO2009059287A3 Generation of biological pacemaker activity
10/08/2009WO2001025256A3 Trdl-1-gamma, a novel tumor necrosis-like ligand
10/08/2009US20090255011 Sweet pepper hybrid 9954288
10/08/2009US20090255009 Cotton variety fm 9150f
10/08/2009US20090255008 Cotton variety fm 9180b2f
10/08/2009US20090255006 Transgenic Zebrafish
10/08/2009US20090255005 Method for Preparing Fish Embryo
10/08/2009US20090255004 G-Protein Coupled Receptor and Uses Therefor
10/08/2009US20090255002 Transgenic Non-Human Animals For Producing Chimeric Antibodies
10/08/2009US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009US20090253781 Therapeutic compositions
10/08/2009US20090253780 COMPOSITIONS AND METHODS RELATED TO miR-16 AND THERAPY OF PROSTATE CANCER
10/08/2009US20090253777 Methods of diagnosing and treating hyperproliferative disorders
10/08/2009US20090253771 Inhibition of gliotoxin
10/08/2009US20090253770 Target gene mimitin of myc
10/08/2009US20090253769 Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
10/08/2009US20090253736 Azaindole derivatives as cftr modulators
10/08/2009US20090253731 Method of identifying therapeutic agents
10/08/2009US20090253699 Compounds for Nonsense Suppression, and Methods for Their Use
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253655 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
10/08/2009US20090253626 50 Human Secreted Proteins
10/08/2009US20090253619 Novel peptide involved in energy homeostasis
10/08/2009US20090253618 Neuronal differentiation-inducing peptide and use thereof
10/08/2009US20090253588 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy
10/08/2009US20090253577 Wheat plants having increased resistance to imidazolinone herbicides
10/08/2009US20090253204 Continuous flow chamber device for separation, concentration, and/or purification of cells
10/08/2009US20090253202 Definitive endoderm
10/08/2009US20090253201 Embryonic stem cells capable of differentiating into desired cell lines
10/08/2009US20090253200 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders
10/08/2009US20090253188 Delta-4 desaturase and its use in making polyunsaturated fatty acids
10/08/2009US20090253184 Compositions and methods related to an adenoviral trans-complementing cell line
10/08/2009US20090253178 Recombinant cell clones having increased stability and methods of making and using the same
10/08/2009US20090253176 Cell lines and methods for producing proteins
10/08/2009US20090253175 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments
10/08/2009US20090253172 Growth factor homolog zvegf4
10/08/2009US20090253170 Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
10/08/2009US20090253167 Methanol-responsive promoter, fusion gene comprising promoter and foreign gene connected so that foreign gene can be expressed, vector, transformant, and method of producing protein
10/08/2009US20090253157 Method of directed differentiation of porcine embryonic stem cells and using the said cells in drug screening
10/08/2009US20090253152 NOVEL MUTANT IGFBP-3 MOLECULES THAT DO NOT BIND TO IGFs, BUT RETAIN THEIR ABILITY TO FUNCTIONALLY BIND IGFBP-3 RECEPTOR
10/08/2009US20090253151 Self-Renewing Master Adult Pluripotent Stem Cells
10/08/2009US20090253148 FLUORESCENCE POLARIZATION hERG ASSAY
10/08/2009US20090253146 Methods of expressing integrin beta6 subunits
10/08/2009US20090253134 Cellular Pyrogen Test
10/08/2009US20090253131 Hybrid fusion reporter and uses thereof
10/08/2009US20090253125 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof
10/08/2009US20090252814 Use of xenon for organ protection
10/08/2009US20090252795 Bioceramic scaffolds for tissue engineering
10/08/2009US20090252784 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same
10/08/2009US20090252783 Means for inhibiting the expression of cd31
10/08/2009US20090252761 Papilloma virus vaccine
10/08/2009US20090252755 nucleic acid molecule comprising a hepatitis C virus (HCV) 5' untranslated region (UTR), produces a HCV that infects chimpanzees; for screening assays for the identification of antiviral agents for HCV
10/08/2009US20090252752 Kdr peptides and vaccines comprising the same
10/08/2009US20090252750 Antibodies and immunotoxins that target human glycoprotein nmb
10/08/2009US20090252748 Sp35 Antibodies and Uses Thereof
10/08/2009US20090252747 Immunization; used to elicit a humoral or cellular immune response
10/08/2009US20090252743 Antibody for use in the treatment of crohn's and inflammatory diseases such as ankylosing spondylitis; human tumor necrosis factor alpha (TNF) inhibitors
10/08/2009US20090252737 T Cell Regulatory Genes And Methods Of Use Thereof
10/08/2009US20090252736 Mammalian Genes; Related Reagents
10/08/2009US20090252733 Generation and Profiling of Fully Human Gold-Derived Therapeutic Antibodies Specific for Human CD38
10/08/2009US20090252730 Contact dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia aereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus; conjugated to polyoxyethylene glycol, serum albumin
10/08/2009US20090252729 Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
10/08/2009US20090252728 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
10/08/2009US20090252727 Glucagon receptor antagonists
10/08/2009US20090252725 Use of CD23 Antibodies to Treat Malignancies in Patients with Poor Prognosis
10/08/2009US20090252722 Botulinum Neurotoxin a Protein Receptor and Uses Thereof
10/08/2009US20090252715 Immortalization of mammalian cells
10/08/2009US20090252712 Chimeric c3-like rho antagonist bone therapeutic
10/08/2009US20090252711 Stem Cells And Methods Of Making And Using Stem Cells
10/08/2009US20090252710 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
10/08/2009US20090252705 IL-6/IL-6R Fusion Protein
10/08/2009US20090252702 Polymer-based anti-cancer agents
10/08/2009US20090252683 Composition Comprising Cross-Species-Sepecific Antibodies and uses Thereof
10/08/2009US20090252681 Nanobodies and Polypeptides Against EGFR and IGF-IR
10/08/2009US20090250609 Inspection Method and Reagent Solution
10/08/2009DE19932688B4 Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen Design of beta-sheet proteins of the gamma-II-crystallin antibody-like
10/08/2009DE102008017990A1 Verfahren zur Herstellung von Dendritischen Zell-ähnlichen Zellen und Einsatz dieser Zellen in in-vitro Testverfahren zur Bestimmung des Einflusses exogener Substanzen Process for the preparation of dendritic cell-like cells, and use of these cells in the in vitro test method for determining the influence of exogenous substances
1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 1827